Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Modeling Human Neurological and Neurodegenerative Diseases: From Induced Pluripotent Stem Cells to Neuronal Differentiation and Its Applications in Neurotrauma.

Bahmad H, Hadadeh O, Chamaa F, Cheaito K, Darwish B, Makkawi AK, Abou-Kheir W.

Front Mol Neurosci. 2017 Feb 28;10:50. doi: 10.3389/fnmol.2017.00050. eCollection 2017. Review.

2.

Cellular Reprogramming Using Protein and Cell-Penetrating Peptides.

Seo BJ, Hong YJ, Do JT.

Int J Mol Sci. 2017 Mar 3;18(3). pii: E552. doi: 10.3390/ijms18030552. Review.

3.

In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation.

Choi HW, Hong YJ, Kim JS, Song H, Cho SG, Bae H, Kim C, Byun SJ, Do JT.

PLoS One. 2017 Jan 31;12(1):e0170735. doi: 10.1371/journal.pone.0170735. eCollection 2017.

4.

Generation of Cholinergic and Dopaminergic Interneurons from Human Pluripotent Stem Cells as a Relevant Tool for In Vitro Modeling of Neurological Disorders Pathology and Therapy.

Ochalek A, Szczesna K, Petazzi P, Kobolak J, Dinnyes A.

Stem Cells Int. 2016;2016:5838934. doi: 10.1155/2016/5838934. Epub 2016 Dec 25. Review.

5.

Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research.

Chandrasekaran A, Avci HX, Leist M, Kobolák J, Dinnyés A.

Front Cell Neurosci. 2016 Sep 26;10:215. eCollection 2016. Review.

6.

Immunogenicity and functional evaluation of iPSC-derived organs for transplantation.

Wang L, Cao J, Wang Y, Lan T, Liu L, Wang W, Jin N, Gong J, Zhang C, Teng F, Yan G, Li C, Li J, Wan H, Hu B, Li W, Zhao X, Qi Z, Zhao T, Zhou Q.

Cell Discov. 2015 Jul 7;1:15015. doi: 10.1038/celldisc.2015.15. eCollection 2015.

7.

In Situ Pluripotency Factor Expression Promotes Functional Recovery From Cerebral Ischemia.

Seo JH, Lee MY, Yu JH, Kim MS, Song M, Seo CH, Kim HH, Cho SR.

Mol Ther. 2016 Sep;24(9):1538-49. doi: 10.1038/mt.2016.124. Epub 2016 Jun 22.

8.

PTEN Promotes Dopaminergic Neuronal Differentiation Through Regulation of ERK-Dependent Inhibition of S6K Signaling in Human Neural Stem Cells.

Lee JE, Lim MS, Park JH, Park CH, Koh HC.

Stem Cells Transl Med. 2016 Oct;5(10):1319-1329. Epub 2016 Jul 7.

9.

Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.

Sarkar S, Raymick J, Imam S.

Int J Mol Sci. 2016 Jun 8;17(6). pii: E904. doi: 10.3390/ijms17060904. Review.

10.

A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects.

Shen Y, Huang J, Liu L, Xu X, Han C, Zhang G, Jiang H, Li J, Lin Z, Xiong N, Wang T.

Front Aging Neurosci. 2016 May 31;8:117. doi: 10.3389/fnagi.2016.00117. eCollection 2016. Review.

11.

Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson's Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations.

Momcilovic O, Sivapatham R, Oron TR, Meyer M, Mooney S, Rao MS, Zeng X.

PLoS One. 2016 May 18;11(5):e0154890. doi: 10.1371/journal.pone.0154890. eCollection 2016.

12.

Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation.

Lewandowski J, Kurpisz M.

Arch Immunol Ther Exp (Warsz). 2016 Oct;64(5):349-70. doi: 10.1007/s00005-016-0385-y. Epub 2016 Mar 3. Review.

13.

History of Neural Stem Cell Research and Its Clinical Application.

Takagi Y.

Neurol Med Chir (Tokyo). 2016;56(3):110-24. doi: 10.2176/nmc.ra.2015-0340. Epub 2016 Feb 16. Review.

14.

Neuroprotective Transcription Factors in Animal Models of Parkinson Disease.

Blaudin de Thé FX, Rekaik H, Prochiantz A, Fuchs J, Joshi RL.

Neural Plast. 2016;2016:6097107. doi: 10.1155/2016/6097107. Epub 2015 Dec 31. Review.

15.

The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside.

Xie N, Tang B.

Stem Cells Int. 2016;2016:6484713. doi: 10.1155/2016/6484713. Epub 2016 Jan 6. Review.

16.

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease.

Kang JF, Tang BS, Guo JF.

Stem Cells Int. 2016;2016:4126214. doi: 10.1155/2016/4126214. Epub 2016 Jan 6. Review.

17.

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges.

Xiao B, Ng HH, Takahashi R, Tan EK.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):697-702. doi: 10.1136/jnnp-2015-312036. Epub 2016 Feb 1. Review.

18.

Pluripotent Stem Cells: Current Understanding and Future Directions.

Romito A, Cobellis G.

Stem Cells Int. 2016;2016:9451492. doi: 10.1155/2016/9451492. Epub 2015 Dec 20. Review.

19.

Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.

Hou L, Kim JJ, Woo YJ, Huang NF.

Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H455-65. doi: 10.1152/ajpheart.00726.2015. Epub 2015 Dec 18. Review.

20.

Differentiation of Human Protein-Induced Pluripotent Stem Cells toward a Retinal Pigment Epithelial Cell Fate.

Gong J, Fields MA, Moreira EF, Bowrey HE, Gooz M, Ablonczy Z, Del Priore LV.

PLoS One. 2015 Nov 25;10(11):e0143272. doi: 10.1371/journal.pone.0143272. eCollection 2015.

Supplemental Content

Support Center